Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK732461 HIV Vaccine Booster with Chloroquine
NCT00972725Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2009
- Primary completion
- Oct 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GSK732461 in human immunodeficiency virus infection (HIV), sponsored by GSK. Started Dec 2009; status: completed.
02
Drugs
GSK732461
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00972725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00972725.